GIS.DE
Price:
$103.9
Market Cap:
$150.40B
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2000-01-03
Stock Exchange
XETRA
Ticker
GIS.DE
Dividends are a key part of long-term returns for investors, and Gilead Sciences, Inc. (GIS.DE) has a track record worth reviewing. Looking at dividend history for GIS.DE gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2025-12-15
Dividend Yield
2.59%
Annual Dividend
$0.68
P/E Ratio
19.24
Payout Ratio
0.61
Dividend per Share
$3.14
EPS
5.40
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2025-12-15 | $0.67851 | $0.67851 | 2025-12-30 | |
| 2025-09-15 | $0.67157 | $0.67157 | 2025-09-29 | |
| 2025-06-13 | $0.67592 | $0.67592 | 2025-06-27 | |
| 2025-03-14 | $0.71045 | $0.71045 | 2025-03-28 | |
| 2024-12-13 | $0.77 | $0.77 | 2024-12-30 | |
| 2024-09-13 | $0.77 | $0.77 | 2024-09-27 | |
| 2024-06-14 | $0.77 | $0.77 | 2024-06-27 | |
| 2024-03-14 | $0.77 | $0.77 | 2024-03-28 | |
| 2023-12-14 | $0.75 | $0.75 | 2023-12-28 | |
| 2023-09-14 | $0.75 | $0.75 | 2023-09-28 | |
| 2023-06-14 | $0.75 | $0.75 | 2023-06-29 |
The table below shows Gilead Sciences, Inc. (GIS.DE) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Gilead Sciences, Inc. (GIS.DE) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Pfizer Inc. (PFE.F) | 0.07% |
| Amgen Inc. (AMG.DE) | 0.03% |
| Pfizer Inc. (PFE.DE) | 0.07% |
| Sanofi (SNW.DE) | 0.05% |
| Bristol-Myers Squibb Company (BRM.DE) | 0.05% |
| Danaher Corporation (DAP.DE) | 0.01% |
| Merck & Co., Inc. (6MK.DE) | 0.03% |
| Stryker Corporation (SYK.DE) | 0.01% |
| Medtronic plc (2M6.DE) | 0.03% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Gilead Sciences, Inc. (GIS.DE) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is GIS.DE’s dividend yield?
What is the difference between regular and special dividends?
Has GIS.DE increased its dividends over time?
Why might dividend history data be delayed?
How often does GIS.DE pay dividends?
What factors impact GIS.DE's dividend payments?
Can dividends change over time?
What is GIS.DE’s next dividend date?